FSCN1 and breast carcinoma: The following sections discuss the molecular action of docetaxel, the known mechanisms by which breast cancer cells evade its effects, the special role of the actin-bundling protein fascin in tumour aggressiveness and drug resistance, an evolutionary perspective on how resistance emerges, and current advances aimed at combating docetaxel resistance.